Destination Wealth Management’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-531
Closed -$48K 384
2019
Q2
$48K Sell
531
-475
-47% -$40.2K ﹤0.01% 280
2019
Q1
$87K Sell
1,006
-95
-9% -$7.63K ﹤0.01% 198
2018
Q4
$85K Buy
1,101
+300
+37% +$23.4K 0.01% 197
2018
Q3
$62K Buy
801
+131
+20% +$9.68K ﹤0.01% 260
2018
Q2
$45K Sell
670
-13
-2% -$897 ﹤0.01% 266
2018
Q1
$49K Buy
+683
New +$52K ﹤0.01% 257

Other funds holding NVS

Destination Wealth Management's NVS Position: Q3 2019 in Review

Destination Wealth Management sold out of Novartis (NVS) in Q3 2019, closing a stake of 531 shares — an estimated $48K sold.

Destination Wealth Management first reported a position in NVS in Q1 2018 and held it in 6 quarters. The position peaked at $87K in Q1 2019. 1,090 funds tracked by Wall St. Rank hold NVS as of Q3 2019.

  • Destination Wealth Management reported no remaining Novartis position as of Q3 2019 after selling out during the quarter.
  • Destination Wealth Management sold 531 Novartis shares in Q3 2019, an estimated $48K.
  • Destination Wealth Management first reported a position in Novartis in Q1 2018 and held it in 6 quarters.
  • Destination Wealth Management's Novartis position peaked at $87K in Q1 2019.
  • 1,090 funds tracked by Wall St. Rank held Novartis as of Q3 2019.

Based on Destination Wealth Management's 13F filing for Q3 2019, filed 13 Nov 2019.